Prepeptide sequence of cinnamycin (Ro 09–0198): the first structural gene of a duramycin‐type lantibiotic

The tetracyclic polypeptide antibiotic cinnamycin (Ro 90–0198) belongs to the duramycin‐type lantibiotics and contains the unusual amino acids threo‐3‐methyl‐lanthionine, meso‐lanthionine, lysinoalanine and 3‐hydroxy‐aspartic acid. Its structural gene, referred to as cinA, has been identified on iso...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of biochemistry 1991-07, Vol.199 (2), p.411-415
Hauptverfasser: KALETTA, Cortina, ENTIAN, Karl‐Dieter, JUNG, Günther
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 415
container_issue 2
container_start_page 411
container_title European journal of biochemistry
container_volume 199
creator KALETTA, Cortina
ENTIAN, Karl‐Dieter
JUNG, Günther
description The tetracyclic polypeptide antibiotic cinnamycin (Ro 90–0198) belongs to the duramycin‐type lantibiotics and contains the unusual amino acids threo‐3‐methyl‐lanthionine, meso‐lanthionine, lysinoalanine and 3‐hydroxy‐aspartic acid. Its structural gene, referred to as cinA, has been identified on isolated chromosomal DNA of the Ro 09–0198‐producing strain Streptoverticillium griseoverticillatum via a 39‐residue oligonucleotide probe derived from fragment 7–19 of the hypothetical prolantibiotic sequence CRQSCSFGPFTFVCDGNTK. This propeptide part was then found within an open reading frame of 77 amino acids. In contrast to the nisin‐type prelantibiotics, this first duramycin‐type prelantibiotic has an unusually long leader sequence of 58 amino acids. It also differs in the processing site and the direction of the formation of the threo‐3‐methyl‐lanthionine bridges is from N‐terminal cysteine to C‐terminal dehydrated threonine residues, whereas the meso‐lanthionine and lysinoalanine bridges are formed by addition reactions from C‐terminal cysteine or lysine to N‐terminal dehyrated serine residues.
doi_str_mv 10.1111/j.1432-1033.1991.tb16138.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80678864</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16025279</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4961-b55ecc467e74f88a332f281e24c3a76e914b89ba6557704649e947d1d78d92653</originalsourceid><addsrcrecordid>eNqVkdtqFTEUhoModbf6CEIQEb2YMZnJsTeipa2FguLhOmQyazSbOTXJYPddH6HgG_ZJOrt72LfS3CzC__1ZK-tH6DUlOZ3Ph3VOWVlklJRlTrWmeaqooKXKr5-g1V56ilaEUJYVmovn6DDGNSFEaCEP0EFBJJGar1D3LcAIY_I14AhXE_QO8NBg5_vedpu54HffB0z03c0_QrV6f4zTH8CNDzHhmMLk0hRsi39D_-CzuJ7vD8a7m9u0GQG3tk--8kPy7gV61tg2wsulHqFfZ6c_T75kl1_PL04-XWaOaUGzinNwjgkJkjVK2bIsmkJRKJgrrRSgKauUrqzgXErCBNOgmaxpLVWtC8HLI_R29-4YhvlPMZnORwftPAoMUzSKCKmUYP8FqSAFL6SeweMd6MIQY4DGjMF3NmwMJWYbilmb7ebNdvNmG4pZQjHXs_nV0mWqOqj31iWFWX-z6DY62zbB9s7HPca5VprRGfu4w_76FjaPGMCcnX7-wSgt7wHz9anK</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16025279</pqid></control><display><type>article</type><title>Prepeptide sequence of cinnamycin (Ro 09–0198): the first structural gene of a duramycin‐type lantibiotic</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>KALETTA, Cortina ; ENTIAN, Karl‐Dieter ; JUNG, Günther</creator><creatorcontrib>KALETTA, Cortina ; ENTIAN, Karl‐Dieter ; JUNG, Günther</creatorcontrib><description>The tetracyclic polypeptide antibiotic cinnamycin (Ro 90–0198) belongs to the duramycin‐type lantibiotics and contains the unusual amino acids threo‐3‐methyl‐lanthionine, meso‐lanthionine, lysinoalanine and 3‐hydroxy‐aspartic acid. Its structural gene, referred to as cinA, has been identified on isolated chromosomal DNA of the Ro 09–0198‐producing strain Streptoverticillium griseoverticillatum via a 39‐residue oligonucleotide probe derived from fragment 7–19 of the hypothetical prolantibiotic sequence CRQSCSFGPFTFVCDGNTK. This propeptide part was then found within an open reading frame of 77 amino acids. In contrast to the nisin‐type prelantibiotics, this first duramycin‐type prelantibiotic has an unusually long leader sequence of 58 amino acids. It also differs in the processing site and the direction of the formation of the threo‐3‐methyl‐lanthionine bridges is from N‐terminal cysteine to C‐terminal dehydrated threonine residues, whereas the meso‐lanthionine and lysinoalanine bridges are formed by addition reactions from C‐terminal cysteine or lysine to N‐terminal dehyrated serine residues.</description><identifier>ISSN: 0014-2956</identifier><identifier>EISSN: 1432-1033</identifier><identifier>DOI: 10.1111/j.1432-1033.1991.tb16138.x</identifier><identifier>PMID: 2070795</identifier><identifier>CODEN: EJBCAI</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Amino Acid Sequence ; Anti-Bacterial Agents - biosynthesis ; Antibiotics (antibacterial agents, antifungal agents) ; Antibiotics, microbial producers, chemotherapic agents, antiseptics, disinfecting agents ; Applied microbiology ; Bacteriocins ; Base Sequence ; Biological and medical sciences ; DNA, Bacterial - genetics ; DNA, Bacterial - isolation &amp; purification ; Fundamental and applied biological sciences. Psychology ; Genes, Bacterial ; Microbiology ; Molecular Sequence Data ; Oligonucleotide Probes ; Peptides, Cyclic ; Plasmids ; Protein Conformation ; Protein Precursors - genetics ; Restriction Mapping ; Sequence Homology, Nucleic Acid ; Streptomycetaceae - genetics</subject><ispartof>European journal of biochemistry, 1991-07, Vol.199 (2), p.411-415</ispartof><rights>1992 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4961-b55ecc467e74f88a332f281e24c3a76e914b89ba6557704649e947d1d78d92653</citedby><cites>FETCH-LOGICAL-c4961-b55ecc467e74f88a332f281e24c3a76e914b89ba6557704649e947d1d78d92653</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=5598941$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2070795$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>KALETTA, Cortina</creatorcontrib><creatorcontrib>ENTIAN, Karl‐Dieter</creatorcontrib><creatorcontrib>JUNG, Günther</creatorcontrib><title>Prepeptide sequence of cinnamycin (Ro 09–0198): the first structural gene of a duramycin‐type lantibiotic</title><title>European journal of biochemistry</title><addtitle>Eur J Biochem</addtitle><description>The tetracyclic polypeptide antibiotic cinnamycin (Ro 90–0198) belongs to the duramycin‐type lantibiotics and contains the unusual amino acids threo‐3‐methyl‐lanthionine, meso‐lanthionine, lysinoalanine and 3‐hydroxy‐aspartic acid. Its structural gene, referred to as cinA, has been identified on isolated chromosomal DNA of the Ro 09–0198‐producing strain Streptoverticillium griseoverticillatum via a 39‐residue oligonucleotide probe derived from fragment 7–19 of the hypothetical prolantibiotic sequence CRQSCSFGPFTFVCDGNTK. This propeptide part was then found within an open reading frame of 77 amino acids. In contrast to the nisin‐type prelantibiotics, this first duramycin‐type prelantibiotic has an unusually long leader sequence of 58 amino acids. It also differs in the processing site and the direction of the formation of the threo‐3‐methyl‐lanthionine bridges is from N‐terminal cysteine to C‐terminal dehydrated threonine residues, whereas the meso‐lanthionine and lysinoalanine bridges are formed by addition reactions from C‐terminal cysteine or lysine to N‐terminal dehyrated serine residues.</description><subject>Amino Acid Sequence</subject><subject>Anti-Bacterial Agents - biosynthesis</subject><subject>Antibiotics (antibacterial agents, antifungal agents)</subject><subject>Antibiotics, microbial producers, chemotherapic agents, antiseptics, disinfecting agents</subject><subject>Applied microbiology</subject><subject>Bacteriocins</subject><subject>Base Sequence</subject><subject>Biological and medical sciences</subject><subject>DNA, Bacterial - genetics</subject><subject>DNA, Bacterial - isolation &amp; purification</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Genes, Bacterial</subject><subject>Microbiology</subject><subject>Molecular Sequence Data</subject><subject>Oligonucleotide Probes</subject><subject>Peptides, Cyclic</subject><subject>Plasmids</subject><subject>Protein Conformation</subject><subject>Protein Precursors - genetics</subject><subject>Restriction Mapping</subject><subject>Sequence Homology, Nucleic Acid</subject><subject>Streptomycetaceae - genetics</subject><issn>0014-2956</issn><issn>1432-1033</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkdtqFTEUhoModbf6CEIQEb2YMZnJsTeipa2FguLhOmQyazSbOTXJYPddH6HgG_ZJOrt72LfS3CzC__1ZK-tH6DUlOZ3Ph3VOWVlklJRlTrWmeaqooKXKr5-g1V56ilaEUJYVmovn6DDGNSFEaCEP0EFBJJGar1D3LcAIY_I14AhXE_QO8NBg5_vedpu54HffB0z03c0_QrV6f4zTH8CNDzHhmMLk0hRsi39D_-CzuJ7vD8a7m9u0GQG3tk--8kPy7gV61tg2wsulHqFfZ6c_T75kl1_PL04-XWaOaUGzinNwjgkJkjVK2bIsmkJRKJgrrRSgKauUrqzgXErCBNOgmaxpLVWtC8HLI_R29-4YhvlPMZnORwftPAoMUzSKCKmUYP8FqSAFL6SeweMd6MIQY4DGjMF3NmwMJWYbilmb7ebNdvNmG4pZQjHXs_nV0mWqOqj31iWFWX-z6DY62zbB9s7HPca5VprRGfu4w_76FjaPGMCcnX7-wSgt7wHz9anK</recordid><startdate>19910715</startdate><enddate>19910715</enddate><creator>KALETTA, Cortina</creator><creator>ENTIAN, Karl‐Dieter</creator><creator>JUNG, Günther</creator><general>Blackwell Publishing Ltd</general><general>Blackwell</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7TM</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>19910715</creationdate><title>Prepeptide sequence of cinnamycin (Ro 09–0198): the first structural gene of a duramycin‐type lantibiotic</title><author>KALETTA, Cortina ; ENTIAN, Karl‐Dieter ; JUNG, Günther</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4961-b55ecc467e74f88a332f281e24c3a76e914b89ba6557704649e947d1d78d92653</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Amino Acid Sequence</topic><topic>Anti-Bacterial Agents - biosynthesis</topic><topic>Antibiotics (antibacterial agents, antifungal agents)</topic><topic>Antibiotics, microbial producers, chemotherapic agents, antiseptics, disinfecting agents</topic><topic>Applied microbiology</topic><topic>Bacteriocins</topic><topic>Base Sequence</topic><topic>Biological and medical sciences</topic><topic>DNA, Bacterial - genetics</topic><topic>DNA, Bacterial - isolation &amp; purification</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Genes, Bacterial</topic><topic>Microbiology</topic><topic>Molecular Sequence Data</topic><topic>Oligonucleotide Probes</topic><topic>Peptides, Cyclic</topic><topic>Plasmids</topic><topic>Protein Conformation</topic><topic>Protein Precursors - genetics</topic><topic>Restriction Mapping</topic><topic>Sequence Homology, Nucleic Acid</topic><topic>Streptomycetaceae - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>KALETTA, Cortina</creatorcontrib><creatorcontrib>ENTIAN, Karl‐Dieter</creatorcontrib><creatorcontrib>JUNG, Günther</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nucleic Acids Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of biochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>KALETTA, Cortina</au><au>ENTIAN, Karl‐Dieter</au><au>JUNG, Günther</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prepeptide sequence of cinnamycin (Ro 09–0198): the first structural gene of a duramycin‐type lantibiotic</atitle><jtitle>European journal of biochemistry</jtitle><addtitle>Eur J Biochem</addtitle><date>1991-07-15</date><risdate>1991</risdate><volume>199</volume><issue>2</issue><spage>411</spage><epage>415</epage><pages>411-415</pages><issn>0014-2956</issn><eissn>1432-1033</eissn><coden>EJBCAI</coden><abstract>The tetracyclic polypeptide antibiotic cinnamycin (Ro 90–0198) belongs to the duramycin‐type lantibiotics and contains the unusual amino acids threo‐3‐methyl‐lanthionine, meso‐lanthionine, lysinoalanine and 3‐hydroxy‐aspartic acid. Its structural gene, referred to as cinA, has been identified on isolated chromosomal DNA of the Ro 09–0198‐producing strain Streptoverticillium griseoverticillatum via a 39‐residue oligonucleotide probe derived from fragment 7–19 of the hypothetical prolantibiotic sequence CRQSCSFGPFTFVCDGNTK. This propeptide part was then found within an open reading frame of 77 amino acids. In contrast to the nisin‐type prelantibiotics, this first duramycin‐type prelantibiotic has an unusually long leader sequence of 58 amino acids. It also differs in the processing site and the direction of the formation of the threo‐3‐methyl‐lanthionine bridges is from N‐terminal cysteine to C‐terminal dehydrated threonine residues, whereas the meso‐lanthionine and lysinoalanine bridges are formed by addition reactions from C‐terminal cysteine or lysine to N‐terminal dehyrated serine residues.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>2070795</pmid><doi>10.1111/j.1432-1033.1991.tb16138.x</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0014-2956
ispartof European journal of biochemistry, 1991-07, Vol.199 (2), p.411-415
issn 0014-2956
1432-1033
language eng
recordid cdi_proquest_miscellaneous_80678864
source MEDLINE; Alma/SFX Local Collection
subjects Amino Acid Sequence
Anti-Bacterial Agents - biosynthesis
Antibiotics (antibacterial agents, antifungal agents)
Antibiotics, microbial producers, chemotherapic agents, antiseptics, disinfecting agents
Applied microbiology
Bacteriocins
Base Sequence
Biological and medical sciences
DNA, Bacterial - genetics
DNA, Bacterial - isolation & purification
Fundamental and applied biological sciences. Psychology
Genes, Bacterial
Microbiology
Molecular Sequence Data
Oligonucleotide Probes
Peptides, Cyclic
Plasmids
Protein Conformation
Protein Precursors - genetics
Restriction Mapping
Sequence Homology, Nucleic Acid
Streptomycetaceae - genetics
title Prepeptide sequence of cinnamycin (Ro 09–0198): the first structural gene of a duramycin‐type lantibiotic
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T21%3A52%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prepeptide%20sequence%20of%20cinnamycin%20(Ro%2009%E2%80%930198):%20the%20first%20structural%20gene%20of%20a%20duramycin%E2%80%90type%20lantibiotic&rft.jtitle=European%20journal%20of%20biochemistry&rft.au=KALETTA,%20Cortina&rft.date=1991-07-15&rft.volume=199&rft.issue=2&rft.spage=411&rft.epage=415&rft.pages=411-415&rft.issn=0014-2956&rft.eissn=1432-1033&rft.coden=EJBCAI&rft_id=info:doi/10.1111/j.1432-1033.1991.tb16138.x&rft_dat=%3Cproquest_cross%3E16025279%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16025279&rft_id=info:pmid/2070795&rfr_iscdi=true